JHx
2021-08-16
Hmm
Have Insiders Been Buying Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares This Year?
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":839300220,"tweetId":"839300220","gmtCreate":1629120882260,"gmtModify":1631890610651,"author":{"id":3573821515865359,"idStr":"3573821515865359","authorId":3573821515865359,"authorIdStr":"3573821515865359","name":"JHx","avatar":"https://static.tigerbbs.com/54eb39bebd911124a59d7bf934977d25","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":16,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Hmm</p></body></html>","htmlText":"<html><head></head><body><p>Hmm</p></body></html>","text":"Hmm","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/839300220","repostId":2146020280,"repostType":2,"repost":{"id":"2146020280","pubTimestamp":1624785138,"share":"https://www.laohu8.com/m/news/2146020280?lang=&edition=full","pubTime":"2021-06-27 17:12","market":"us","language":"en","title":"Have Insiders Been Buying Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares This Year?","url":"https://stock-news.laohu8.com/highlight/detail?id=2146020280","media":"Simply Wall St.","summary":"It is not uncommon to see companies perform well in the years after insiders buy shares. On the othe","content":"<html><body><p>It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we'd be remiss not to mention that insider sales have been known to precede tough periods for a business. So we'll take a look at whether insiders have been buying or selling shares in <strong><a href=\"https://laohu8.com/S/EWTX\">Edgewise Therapeutics, Inc.</a></strong> (NASDAQ:EWTX). </p>\n<h3> What Is Insider Selling? </h3>\n<p> It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, most countries require that the company discloses such transactions to the market. </p>\n<p> Insider transactions are not the most important thing when it comes to long-term investing. But it is perfectly logical to keep tabs on what insiders are doing. As Peter Lynch said, 'insiders might sell their shares for any number of reasons, but they buy them for only <a href=\"https://laohu8.com/S/AONE\">one</a>: they think the price will rise'. </p>\n<p><span> View our latest analysis for Edgewise Therapeutics </span></p>\n<h3> The Last 12 Months Of Insider Transactions At Edgewise Therapeutics </h3>\n<p> In the last twelve months, the biggest single purchase by an insider was when Independent Director Jonathan Root bought US$250k worth of shares at a price of US$16.00 per share. Although we like to see insider buying, we note that this large purchase was at significantly below the recent price of US$23.95. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive. </p>\n<p> In the last twelve months Edgewise Therapeutics insiders were buying shares, but not selling. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction! </p>\n<figure>\n<img src=\"https://s1.yimg.com/uu/api/res/1.2/r9P8iDHu1pvu17L7EwOjNA--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/simply_wall_st__316/975f24496687ccff1b1b6f993ba57d4b\"/>\n<figcaption>\n NasdaqGS:EWTX Insider Trading Volume June 27th 2021\n </figcaption>\n</figure>\n<p> Edgewise Therapeutics is not the only stock insiders are buying. So take a peek at this <strong>free</strong> list of growing companies with insider buying. </p>\n<h3> Insiders at Edgewise Therapeutics Have Bought Stock Recently </h3>\n<p> Over the last three months, we've seen significant insider buying at Edgewise Therapeutics. In total, insiders bought US$500k worth of shares in that time, and we didn't record any sales whatsoever. This makes <a href=\"https://laohu8.com/S/AONE.U\">one</a> think the business has some good points. </p>\n<h3> Does Edgewise Therapeutics Boast High Insider Ownership? </h3>\n<p> Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. It appears that Edgewise Therapeutics insiders own 1.3% of the company, worth about US$16m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders. </p>\n<h3> What Might The Insider Transactions At Edgewise Therapeutics Tell Us? </h3>\n<p> It is good to see recent purchasing. We also take confidence from the longer term picture of insider transactions. But we don't feel the same about the fact the company is making losses. Insiders likely see value in Edgewise Therapeutics shares, given these transactions (along with notable insider ownership of the company). In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Edgewise Therapeutics. Every company has risks, and we've spotted <strong>3 warning signs for Edgewise Therapeutics</strong> (of which 1 is potentially serious!) you should know about. </p>\n<p> If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this <strong>free</strong> list of interesting companies, that have HIGH return on equity and low debt. </p>\n<p><em>For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.</em></p>\n<p><i>This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</i><br/><br/><strong>Have feedback on this article? Concerned about the content?</strong> <strong>Get in touch</strong><strong> with us directly.</strong><i> Alternatively, email editorial-team (at) simplywallst.com.</i></p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Have Insiders Been Buying Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares This Year?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHave Insiders Been Buying Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares This Year?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-27 17:12 GMT+8 <a href=https://finance.yahoo.com/news/insiders-buying-edgewise-therapeutics-inc-091218917.html><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we'd be remiss not to mention that insider sales have been known to precede tough periods ...</p>\n\n<a href=\"https://finance.yahoo.com/news/insiders-buying-edgewise-therapeutics-inc-091218917.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/hJQLyA1Q_mPULMpcG.nG9g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/TLyt5D16lsSwRjJRVjlUTA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b","relate_stocks":{"EWTX":"Edgewise Therapeutics, Inc.","CRCT":"Cricut, Inc.","TERN":"Terns Pharmaceuticals, Inc."},"source_url":"https://finance.yahoo.com/news/insiders-buying-edgewise-therapeutics-inc-091218917.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2146020280","content_text":"It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we'd be remiss not to mention that insider sales have been known to precede tough periods for a business. So we'll take a look at whether insiders have been buying or selling shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX). \n What Is Insider Selling? \n It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, most countries require that the company discloses such transactions to the market. \n Insider transactions are not the most important thing when it comes to long-term investing. But it is perfectly logical to keep tabs on what insiders are doing. As Peter Lynch said, 'insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise'. \n View our latest analysis for Edgewise Therapeutics \n The Last 12 Months Of Insider Transactions At Edgewise Therapeutics \n In the last twelve months, the biggest single purchase by an insider was when Independent Director Jonathan Root bought US$250k worth of shares at a price of US$16.00 per share. Although we like to see insider buying, we note that this large purchase was at significantly below the recent price of US$23.95. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive. \n In the last twelve months Edgewise Therapeutics insiders were buying shares, but not selling. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction! \n\n\n\n NasdaqGS:EWTX Insider Trading Volume June 27th 2021\n \n\n Edgewise Therapeutics is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying. \n Insiders at Edgewise Therapeutics Have Bought Stock Recently \n Over the last three months, we've seen significant insider buying at Edgewise Therapeutics. In total, insiders bought US$500k worth of shares in that time, and we didn't record any sales whatsoever. This makes one think the business has some good points. \n Does Edgewise Therapeutics Boast High Insider Ownership? \n Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. It appears that Edgewise Therapeutics insiders own 1.3% of the company, worth about US$16m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders. \n What Might The Insider Transactions At Edgewise Therapeutics Tell Us? \n It is good to see recent purchasing. We also take confidence from the longer term picture of insider transactions. But we don't feel the same about the fact the company is making losses. Insiders likely see value in Edgewise Therapeutics shares, given these transactions (along with notable insider ownership of the company). In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Edgewise Therapeutics. Every company has risks, and we've spotted 3 warning signs for Edgewise Therapeutics (of which 1 is potentially serious!) you should know about. \n If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt. \nFor the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.\nThis article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.","news_type":1},"isVote":1,"tweetType":1,"viewCount":214,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":3,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/839300220"}
精彩评论